Two stable Fenton oxidation products of cyclophosphamide (NSC 26271) as precursors of 4 hydroxycyclophosphamide (NSC 196562) under physiologic conditions

PMID: 945125
11Citations
Citations of this article
2Readers
Mendeley users who have this article in their library.

Abstract

Cytostatic and chemical properties of two cyclophosphamide (CP) 4 peroxides, 4 hydroperoxycyclophosphamide and 4 hydroxycyclophosphamide anhydro dimer, that were earlier isolated and identified after Fenton oxidation of CP, are summarized and discussed. Their cytostatic toxicities, which are quantitatively comparable in those of the primary metabolite of CP, 4 hydroxycyclophosphamide, are explained from their apparent spontaneous conversion to mono oxidized forms of CP, both in vitro and in vivo. The conversion is shown to proceed via autocatalyzed reactions, which are thought to imply the occurrence of free radicals during deoxygenation. The point is raised whether any qualitative difference in cytotoxicity might be caused by the action of these free radicals. Current dose effect studies of residual colony forming ability after treatment of 3T6 mouse fibroblasts and Yoshida sarcoma cells in suspension culture are introduced. Further studies on the local toxic action of the radicals under in vivo conditions are necessary if the peroxides are to be introduced in local or regional clinical treatments.

Cite

CITATION STYLE

APA

Benckhuysen, C., Van Der Steen, J., & Spanjersberg, E. J. (1976). Two stable Fenton oxidation products of cyclophosphamide (NSC 26271) as precursors of 4 hydroxycyclophosphamide (NSC 196562) under physiologic conditions. CANCER TREAT.REP., 60(4), 369–372.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free